REGN
REGENERON PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Biotechnology · US
$818.77
+0.68%Forward multiples
Based on analyst estimates
- P/E forward
- 12.11x
- P/E 2026E
- 13.60x
- P/E 2027E
- 12.84x
- P/E 2028E
- 11.65x
- P/S forward
- 4.40x
Trailing multiples
Trailing twelve months
- P/E TTM
- 19.55x
- PEG TTM
- 0.32x
- Price / book
- 2.66x
- Price / sales
- 5.43x
- Price / cash flow
- 18.97x
Enterprise value
- Enterprise value
- $78.3B
- EV / sales
- 5.04x
- EV / EBITDA
- 13.62x
- EV / EBIT
- 19.72x
- Market cap
- $84.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026